Empagliflozin reduces the doxorubicine-induced myocardial dysfunction.

28 August 2017 (14:00 - 18:00)
Organised by:
Congress Presentation Part of: Best Posters 5 - Best Posters in comorbidities in heart failure Ventricular function / haemodynamics ESC Premium Access ESC Congress 2017

About the speaker

Photo

Magna Graecia University of Catanzaro, Catanzaro (Italy)

4 More presentations in this session

Presentation thumbnail
Doctor P. Efentakis (Athens, GR)
Presentation thumbnail
Associate Professor A. Soloveva (Saint Petersburg, RU)
Presentation thumbnail
Mrs M. Olofsson (Skelleftea, SE)

The Event

Event poster

ESC Congress 2017

28 August 2017 14:00 CET

ESC 365 is supported by

ESC 365 is supported by